Federated Hermes

Federated Hermes’s Enliven Therapeutics ELVN Stock Holding History

Federated Hermes’s Portfolio ELVN Stock Details ELVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,811	Closed	-$221K	–	2098
2025 Q3	$221K	Sell	10,811 -5,287	-33%	-$107K	﹤0.01%	1491
2025 Q2	$323K	Sell	16,098 -52,953	-77%	-$1M	﹤0.01%	1426
2025 Q1	$1.36M	Sell	69,051 -48,501	-41%	-$1.04M	﹤0.01%	1031
2024 Q4	$2.64M	Buy	+117,552	New	+$3.05M	0.01%	871
2023 Q2	–	Sell	-243	Closed	-$5.32K	–	2136
2023 Q1	$5.32K	Sell	243 -17	-7%	-$346	﹤0.01%	1928
2022 Q4	$4.25K	Sell	260 -134	-34%	-$2.14K	﹤0.01%	1942
2022 Q3	$4K	Sell	394 -542	-58%	-$3.2K	﹤0.01%	1907
2022 Q2	$5K	Sell	936 -24	-3%	-$117	﹤0.01%	1895
2022 Q1	$7K	Buy	960 +266	+38%	+$1.75K	﹤0.01%	1916
2021 Q4	$6K	Buy	694 +275	+66%	+$3.61K	﹤0.01%	1976
2021 Q3	$7K	Buy	+419	New	+$8.71K	﹤0.01%	2017

Other funds holding ELVN

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return